Pain News and Research

Latest Pain News and Research

Research opens door to new direction of PAH treatment

The development of new, more effective vasodilators to treat pulmonary arterial hypertension has been hampered because of their systemic toxicity and adverse side effects. An international team of investigators seeking to surmount these problems and increase drug efficacy have determined that a vascular homing peptide can selectively target hypertensive pulmonary arteries to boost the pulmonary but not systemic effects of vasodilators. Importantly for potential clinical use, this peptide retains its activity when given sublingually. The results using a rat model of PAH are published in the American Journal of Pathology.

8 Jan 2014

Study sheds light on the biological underpinnings of obesity

A new neuroscience study sheds light on the biological underpinnings of obesity. The in vivo study, published in the January 8 issue of the Journal of Neuroscience, reveals how a protein in the brain helps regulate food intake and body weight. The findings reveal a potential new avenue for the treatment of obesity and may help explain why medications that are prescribed for epilepsy and other conditions that interfere with this protein, such as gabapentin and pregabalin, can cause weight gain.

7 Jan 2014

Barriers persist to new approaches to medical liability, studies find

Issues of medical liability and tort reform, as well as how they interact with rising health care costs, continue to draw news media interest.

7 Jan 2014

Navidea Biopharmaceuticals, GMST sign distribution agreement for Lymphoseek Injection in Taiwan

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today it has entered into a distribution agreement for Lymphoseek (technetium Tc 99m tilmanocept) Injection in Taiwan with Global Medical Solutions Taiwan, Ltd., a leading in-country distributor of nuclear medicine and diagnostic imaging products.

7 Jan 2014

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Commission has granted approval for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas, or metastatic pancreatic cancer.

7 Jan 2014

Synthetic cannabinoid molecule created for osteoarthritis

Chemical compounds synthesised in the laboratory, similar to those found in cannabis, could be developed as potential drugs to reduce the pain of osteoarthritis.

7 Jan 2014

Bunker Vein and Imaging Center starts second location in Round Rock

Bunker Vein and Imaging Center is proud to announce its second location, which opened this month in Round Rock, Texas. Dr. Stephen Bunker and his medical team have been treating patients with varicose veins, spider veins and venous disease for over five years in the Central Austin area.

7 Jan 2014

Virginia Tech associate professor receives PECASE award to study pelvic disorders

In 2012, Raffaella De Vita received a National Science Foundation Faculty Early Development Award to lead a national study on pelvic floor disorders, affecting some one third of adult American women.

7 Jan 2014

JLR Medical Group becomes founding partner in U.S. Anesthesia Partners

JLR Medical Group, one of Florida's largest anesthesia practices, today announced it will become a founding partner in U.S. Anesthesia Partners ("USAP"), an anesthesia-focused physician services organization.

7 Jan 2014

Research: Daily meditation may improve symptoms of anxiety and depression

Some 30 minutes of meditation daily may improve symptoms of anxiety and depression, a new Johns Hopkins analysis of previously published research suggests.

7 Jan 2014

Mutations in small proteins that help convey electrical signals may influence nerve health

Mutations in small proteins that help convey electrical signals throughout the body may have a surprisingly large effect on health, according to results of a new Johns Hopkins study study published in Proceedings of the National Academy of Sciences in December using spider, scorpion and sea anemone venom.

7 Jan 2014

Ossianix forms strategic research partnership with Lundbeck

Ossianix, Inc. today announced a strategic research collaboration with Lundbeck A/S. This collaboration follows a previous investment in 2012. The collaboration uses Ossianix's innovative single domain antibody platform based on the shark VNAR structure and will focus on two projects.

6 Jan 2014

Implanting tubes in ears is less likely to improve long-term cognitive and functional development

Watchful waiting or ear tube surgery? It is a decision faced by millions of families of children with recurrent or chronic otitis media with effusion (non-infected fluid in the middle ear) each year.

6 Jan 2014

Amneal launches generic Esomeprazole strontium delayed-release capsules 49.3 mg

Amneal Pharmaceuticals LLC today announced the launch of generic Esomeprazole strontium delayed-release capsules 49.3 mg. This new esomeprazole therapy is the generic equivalent of the recently launched brand Esomeprazole strontium. It contains the same active moiety (esomeprazole) in a different salt form as found in the leading PPI brand Nexium (esomeprazole magnesium) and presents a potentially more affordable treatment option for GERD in adult patients.

6 Jan 2014

Special publication details breakthrough research on causes of vascular disease

The world's leading voices in the fight against Pulmonary Hypertension have compiled a special publication detailing the breakthrough research into the causes of this debilitating vascular disease.

6 Jan 2014

Researchers study changes in gray matter volume in chronic back pain patients

Accumulating evidence indicates that chronic pain of different etiologies is often associated with distinct gray matter volume reductions in multiple brain regions associated with acute pain processing, and gray matter atrophy critically affects the perception and modulation of chronic pain.

6 Jan 2014

RegeneRx's Tβ4 gets FDA Orphan Drug designation for treatment of Neurotrophic Keratopathy

RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).

5 Jan 2014

Study explores safety and efficacy of scoop and run approach in Philadelphia

A new study from the Perelman School of Medicine at the University of Pennsylvania has found no significant difference in adjusted overall survival rates between gunshot and stabbing (so-called penetrating trauma injuries) victims in Philadelphia whether they were transported to the emergency department by the police department or the emergency medical services division of the fire department.

3 Jan 2014

UC Davis docs find a way to create "movies" of wrist in motion using magnetic resonance imaging scans

If a picture is worth 1,000 words then a movie is worth far more, especially when it comes to diagnosing wrist problems.

3 Jan 2014

Chinese herbal medicine effective at alleviating acute inflammatory and nerve pain

A compound derived from a traditional Chinese herbal medicine has been found effective at alleviating pain, pointing the way to a new nonaddictive analgesic for acute inflammatory and nerve pain, according to UC Irvine pharmacology researchers.

3 Jan 2014

Pain News and Research

Latest Pain News and Research

Research opens door to new direction of PAH treatment

Study sheds light on the biological underpinnings of obesity

Barriers persist to new approaches to medical liability, studies find

Navidea Biopharmaceuticals, GMST sign distribution agreement for Lymphoseek Injection in Taiwan

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

Synthetic cannabinoid molecule created for osteoarthritis

Bunker Vein and Imaging Center starts second location in Round Rock

Virginia Tech associate professor receives PECASE award to study pelvic disorders

JLR Medical Group becomes founding partner in U.S. Anesthesia Partners

Research: Daily meditation may improve symptoms of anxiety and depression

Mutations in small proteins that help convey electrical signals may influence nerve health

Ossianix forms strategic research partnership with Lundbeck

Implanting tubes in ears is less likely to improve long-term cognitive and functional development

Amneal launches generic Esomeprazole strontium delayed-release capsules 49.3 mg

Special publication details breakthrough research on causes of vascular disease

Researchers study changes in gray matter volume in chronic back pain patients

RegeneRx's Tβ4 gets FDA Orphan Drug designation for treatment of Neurotrophic Keratopathy

Study explores safety and efficacy of scoop and run approach in Philadelphia

UC Davis docs find a way to create "movies" of wrist in motion using magnetic resonance imaging scans

Chinese herbal medicine effective at alleviating acute inflammatory and nerve pain

Industry Focus eBook - Pharmaceutical Manufacturing (1st edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Pain News and Research

Latest Pain News and Research

Industry Focus eBook - Pharmaceutical Manufacturing (1st edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in